Mariner
VRCA icon

Mariner’s Verrica Pharmaceuticals VRCA Stock Holding History

Mariner’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$130K Hold
24,544
– – ﹤0.01% 3275
2025
Q4 		$204K Sell
24,544
-6
-0% -$33 ﹤0.01% 3155
2025
Q3 		$106K Sell
24,550
-1,980
-7% -$11.9K ﹤0.01% 3344
2025
Q2 		$141K Buy
26,530
+10,011
+61% +$53.9K ﹤0.01% 3164
2025
Q1 		$73K Buy
16,519
+7,541
+84% +$48.8K ﹤0.01% 3247
2024
Q4 		$62.8K Sell
8,978
-16
-0.2% -$176 ﹤0.01% 3262
2024
Q3 		$130K Buy
8,994
+7,245
+414% +$326K ﹤0.01% 3041
2024
Q2 		$127K Hold
1,749
– – ﹤0.01% 2901
2024
Q1 		$104K Buy
+1,749
New +$96.6K ﹤0.01% 2924

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mariner's VRCA Position: Q1 2026 in Review

Mariner held its Verrica Pharmaceuticals (VRCA) position steady in Q1 2026 at 24,544 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #3275.

Mariner first reported a position in VRCA in Q1 2024 and has held it in 9 quarters since. The position peaked at $204K in Q4 2025. 39 funds tracked by Wall St. Rank hold VRCA as of Q1 2026.

  • Mariner held 24,544 shares of Verrica Pharmaceuticals worth $130K as of Q1 2026.
  • Mariner left its Verrica Pharmaceuticals share count unchanged in Q1 2026.
  • Verrica Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3275 holding.
  • Mariner first reported a position in Verrica Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Mariner's Verrica Pharmaceuticals position peaked at $204K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.